Mucinex 12 Hour Guaifenesin Extended-Release Tablets for Excess Mucus Relief

Mucinex 12hr Extended-Release Tablets: A Powerful Solution for Excess Mucus Relief Providing long-lasting chest congestion relief, Mucinex 12hr extended-release tablets pack a potent punch with 600 mg of the expectorant guaifenesin. This extended-release formulation offers you the convenience of up to 12 hours of symptom management.

Mucinex SE: Effectively Clearing Excess Mucus Mucinex SE provides effective chest congestion relief by thinning and loosening mucus, making coughs more productive. This long-lasting formula offers relief for up to 12 hours, helping you breathe easier and regain control over your respiratory health.

Expectorants for Adults: Clearing Lungs, Relieving Congestion Mucinex is designed to help clear your lungs by thinning and loosening excess mucus. Say goodbye to the discomfort of excess mucus and hello to the relief of reduced chest congestion.

Extended-Release Guaifenesin: Long-Lasting Excess Mucus Relief Experience the benefits of Mucinex's 12-hour extended-release 600 mg guaifenesin tablets. The original bi-layer tablets provide both immediate and extended-release action, ensuring long-lasting excess mucus relief.

Trusted Brand: Doctors' and Pharmacists' Choice Mucinex is the #1 Cough & Cold Brand that Doctors Trust and the #1 Pharmacist Recommended OTC Expectorant*. Trust the brand that healthcare professionals trust and recommend for your cough, cold, and flu relief needs.

Mucinex Fast-Max: Powerful Cold and Flu Symptom Relief For comprehensive cough, cold, and flu multi-symptom relief, explore our range of Mucinex Fast-Max products. Confront cold and flu symptoms with confidence, knowing you have the power of Mucinex on your side.

FSA and HSA Eligibility: Save Up to 30% with Pre-Tax Dollars Eligible Mucinex products can be purchased using pre-tax dollars from your Flexible Spending Account (FSA) or Health Savings Account (HSA), allowing you to save up to 30% on out-of-pocket expenses. Check with your benefits administrator to determine which expenses are eligible before making your purchase.

IQVIA using ProVoice Survey, August 2023 *U.S. News & World Report/Pharmacy Times 2023-2024

product information: